Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EBIT: 2019-2024

Historic EBIT for Biodesix (BDSX) over the last 6 years, with Dec 2024 value amounting to -$34.5 million.

  • Biodesix's EBIT rose 17.93% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.6 million, marking a year-over-year increase of 6.23%. This contributed to the annual value of -$34.5 million for FY2024, which is 16.55% up from last year.
  • According to the latest figures from FY2024, Biodesix's EBIT is -$34.5 million, which was up 16.55% from -$41.3 million recorded in FY2023.
  • Over the past 5 years, Biodesix's EBIT peaked at -$22.9 million during FY2020, and registered a low of -$50.6 million during FY2022.
  • In the last 3 years, Biodesix's EBIT had a median value of -$41.3 million in 2023 and averaged -$42.1 million.
  • Its EBIT has fluctuated over the past 5 years, first tumbled by 78.51% in 2021, then grew by 18.28% in 2023.
  • Biodesix's EBIT (Yearly) stood at -$22.9 million in 2020, then crashed by 78.51% to -$40.9 million in 2021, then declined by 23.56% to -$50.6 million in 2022, then climbed by 18.28% to -$41.3 million in 2023, then increased by 16.55% to -$34.5 million in 2024.